Personalizing patient care with medicines: Innovative models of care from the United Kingdom

Abstract

Abstract This chapter explores the role of the pharmacist in personalizing pharmaceutical care and presents the findings of two key projects from UK clinical practice. The chapter begins with an overview of personalized care in the UK context and definitions, followed by strategy and guidance. The first project outlines a deprescribing model, “SHINE,” led by pharmacists through use of a shared decision-making framework to embed personalized care. Results, benefits, and challenges faced in implementation are discussed. The second project illustrates how personalized care can be achieved in group consultations. We introduce the concept of group consultations (also known as “group clinics” or “shared medical appointments”) and the various model designs in operation globally. We then present the findings of our non-inferiority randomized controlled trial of a pharmacist-led osteoporosis group clinic. The benefits to personalization of care, while optimizing efficiency and patient/healthcare worker satisfaction, are described and potential challenges discussed.